Tier 1 Canada Research Chair (CRC) in Metabolomics for Novel Therapeutics
The Schulich School of Medicine & Dentistry at The University of Western Ontario invites applications for a Tier 1 Canada Research Chair (CRC) in Metabolomics for Novel Therapeutics. The successful candidate will be appointed to a full-time tenured joint appointment at the rank of Associate Professor or Professor in the Department of Biochemistry, in the Schulich School of Medicine & Dentistry, and jointly in the Department of Chemistry in the Faculty of Science. The rank and tenure status will be commensurate with qualifications and experience. The successful candidate may be appointed to potential cross appointment(s) in other relevant departments at their request.
In recognition of Western’s commitment to equity, diversity and inclusion, and in recognition of the underrepresentation of Women in our Chairholders and pursuant to Section 14 of the Ontario Human Rights Code, only applicants who self-identify as a woman will be considered for this CRC opportunity. The CRC Program includes individuals from Gender Equity-Seeking Groups in the designated group of Women. This includes individuals who self-identify as transgender, gender-fluid, non-binary and Two-Spirit. Applicants will be required to self-identify to the appointments committee members in their application for the position. Candidates must complete the CRC Application Form and submit it with their application materials.
Metabolomics is an area of research that can be used to study both healthy populations as well as many different acute and chronic diseases... [full details on research focus, qualifications, etc.]
The successful candidate will hold a PhD or equivalent... [qualifications summary]
In accordance with the criteria for a Tier 1 CRC appointment (www.chairs-chaires.gc.ca/) the successful candidate must be an outstanding and innovative world-class researcher...
Applications will be reviewed by a multi-disciplinary committee and must include: [list of required documents]
The application package should be assembled into a single PDF document for submission to Dr. Gloor via email to jessica.jamieson@schulich.uwo.ca.
The anticipated start date will be July 1, 2026 or as negotiated...
Whoops! This job is not yet sponsored…
Or, view more options below
View full job details
See the complete job description, requirements, and application process
Express interest in this position
Let AcademicJobs.com know you're interested in Tier 1 Canada Research Chair (CRC) in Metabolomics for Novel Therapeutics
Get similar job alerts
Receive notifications when similar positions become available

